Ignite Creation Date:
2025-12-25 @ 2:23 AM
Ignite Modification Date:
2026-03-07 @ 9:55 AM
Study NCT ID:
NCT04147234
Status:
COMPLETED
Last Update Posted:
2025-08-19
First Post:
2019-10-30
Is Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
A Study to Find the Best Dose of BI 1387446 Alone or in Combination With Ezabenlimab (BI 754091) in Patients With Different Types of Advanced or Metastatic Cancer (Solid Tumors)
Sponsor:
Boehringer Ingelheim
Organization:
Conditions & Keywords Data
Conditions:
Conditions
| Condition Brief | Condition Text | View |
|---|---|---|
| None | Neoplasms | View |
Keywords: